Risk Stratification and Distribution of Hepatocellular Carcinomas in CEUS and CT/MRI LI-RADS: A Meta-Analysis

Risk Stratification and Distribution of Hepatocellular Carcinomas in CEUS and CT/MRI LI-RADS: A Meta-Analysis

BackgroundCEUS LI-RADS and CT/MRI LI-RADS have been used in clinical practice for several years. However, there is a lack of evidence-based study to compare the proportion of hepatocellular carcinomas (HCCs) in each category and the distribution of HCCs of these two categorization systems.PurposeThe...

Full description

Bibliographic Details
Main Authors:	Yan Zhou, Zhengyi Qin, Jianmin Ding, Lin Zhao, Ying Chen, Fengmei Wang, Xiang Jing
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Oncology
Subjects:	contrast-enhanced ultrasound contrast-enhanced magnetic resonance imaging Contrast-enhanced computed tomography hepatocellular carcinoma Liver Imaging Reporting and Data System
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.873913/full

Similar Items

CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma
by: Yan Zhou, et al.
Published: (2022-05-01)

Differences in CEUS and CE-MRI Appearance of HCC: A Case Report
by: Li Ma, MD, Wenzhao Liang, MD, Yupeng Zhu, MD, Yingqiao Zhu, MD, Dezhi Zhang, MD
Published: (2019-12-01)

CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors
by: Zhe Huang, et al.
Published: (2023-03-01)

FI-CEUS: a solution to improve the diagnostic accuracy in MRI LI-RADS-indeterminate (LR-3/4) FLLs at risk for HCC
by: Qingjing Zeng, et al.
Published: (2024-01-01)

Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS
by: Yi-Xin Hu, et al.
Published: (2021-04-01)

LI-RADS ancillary features on contrast-enhanced ultrasonography
by: Christoph F. Dietrich, et al.
Published: (2020-07-01)

CEUS cardiac exam protocols International Contrast Ultrasound Society (ICUS) recommendations
by: Thomas R. Porter, et al.
Published: (2022-08-01)

Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma
by: Katsutoshi Sugimoto, et al.
Published: (2023-07-01)

CEUS LI-RADS: a pictorial review
by: Tommaso Vincenzo Bartolotta, et al.
Published: (2020-02-01)

Contrast-Enhanced Imaging Features and Clinicopathological Investigation of Steatohepatitic Hepatocellular Carcinoma
by: Kailing Chen, et al.
Published: (2023-04-01)

Contrast-Enhanced Ultrasound for Monitoring Treatment Response in Different Stages of Hepatocellular Carcinoma
by: Mariella Faccia, et al.
Published: (2022-01-01)

Structured Reporting Using CEUS LI-RADS for the Diagnosis of Hepatocellular Carcinoma (HCC)—Impact and Advantages on Report Integrity, Quality and Interdisciplinary Communication
by: Thomas Geyer, et al.
Published: (2021-01-01)

Diagnostic Value of CEUS LI-RADS Version 2017 in Differentiating AFP-Negative Hepatocellular Carcinoma from Other Primary Malignancies of the Liver
by: Peihua Wang, et al.
Published: (2021-12-01)

CEUS
by: F. J. Ten Cate
Published: (2015-01-01)

The Role of Contrast-Enhanced Ultrasound (CEUS) in the Detection of Neoplastic Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma
by: Lucia Cerrito, et al.
Published: (2023-10-01)

Application of the CT/MRI LI-RADS Treatment Response Algorithm to Contrast-Enhanced Ultrasound: A Feasibility Study
by: Ruan SM, et al.
Published: (2022-05-01)

Diagnostic Value of CEUS Prompting Liver Biopsy: Histopathological Correlation of Hepatic Lesions with Ambiguous Imaging Characteristics
by: Thomas Geyer, et al.
Published: (2020-12-01)

Contrast-enhanced ultrasound in the diagnosis of infiltrative hepatocellular carcinoma: A report of three cases
by: Yasovineeth Bhogadi, BSc, et al.
Published: (2021-03-01)

Value of CEUS features in diagnosing thyroid nodules with halo sign on B-mode ultrasound
by: Xue-jun Chen, et al.
Published: (2023-01-01)

Contrast‐enhanced ultrasound (CEUS) of benign and malignant renal tumors: Distinguishing CEUS features differ with tumor size
by: Jianing Zhu, et al.
Published: (2023-02-01)

Time-intensity Curve Analysis of Hepatocellular Carcinoma using Two Contrast-enhanced Ultrasound Methods: Contrast Pulse Sequencing and Contrast Harmonic Imaging
by: Mengna He, MD, PhD, Lei Xu, MD, Tian’an Jiang, MD, PhD
Published: (2020-09-01)

Discrepancy of contrast-enhanced ultrasonographic pattern with two contrast agents in steatohepatitic subtype hepatocellular carcinoma: A case report
by: Jiang Bo, MD, et al.
Published: (2022-06-01)

Contrast-Enhanced Ultrasound LI-RADS: A Pictorial Review
by: Osama Mahmoud, BS, Ajay Makkena, BS, Corinne E. Wessner, MS, MBA, RDMS, Ji-Bin Liu, MD, John R. Eisenbrey, PhD, Andrej Lyshchik, MD, PhD
Published: (2023-12-01)

Diagnostic Values of CEUS, CECT and CEMRI for Renal Cystic Lesions on the Current Bosniak Criterion-A Meta-analysi
by: Xiaojuan Yang, MD, Huihui Yang, MD, Yu He,MD, PhD
Published: (2022-12-01)

Case Report: The value of contrast-enhanced ultrasound and contrast-enhanced computed tomography in the diagnosis of hepatic angiosarcoma
by: Feiqian Wang, et al.
Published: (2023-12-01)

A Nomogram Based on Combining Clinical Features and Contrast Enhanced Ultrasound LI-RADS Improves Prediction of Microvascular Invasion in Hepatocellular Carcinoma
by: Hang Zhou, et al.
Published: (2021-07-01)

Contrast-Enhanced Ultrasonography (CEUS) in Imaging of the Reproductive System in Dogs: A Literature Review
by: Letizia Sinagra, et al.
Published: (2023-05-01)

Clinical Value of Contrast-enhanced Ultrasound in Differential Diagnosis of Early Hepatocellular Carcinoma and Dysplastic Nodules
by: Jianmin Ding, MD, Yan Zhou, MD, Yandong Wang, MD, Hongyu Zhou, MD, Xiang Jing, MD
Published: (2017-03-01)

Applications in Molecular Ultrasound Imaging: Present and Future
by: Vishal Thumar, MD, Ji-Bin Liu, MD, John Eisenbrey, PhD
Published: (2019-09-01)

Diagnosis of intrahepatic cholangiocarcinoma with CEUS
by: Velardi Giancarlo Gismondo, et al.
Published: (2024-02-01)

The definitive role of CEUS in an ambiguous case of renal cell carcinoma
by: Drelich Katarzyna, et al.
Published: (2021-08-01)

Addition of contrast in ultrasound screening for hepatocellular carcinoma
by: Kathryn McGillen, et al.
Published: (2024-03-01)

Predicting Therapeutic Efficacy of Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound
by: Kazue Shiozawa, et al.
Published: (2021-02-01)

Use of Contrast-Enhanced Ultrasound with Sonazoid for Evaluating the Radiotherapy Efficacy for Hepatocellular Carcinoma
by: Akihiro Funaoka, et al.
Published: (2021-03-01)

Diffusion-weighted imaging compared to dynamic MRI in early response assessment of locoregional therapy (by trans-arterial chemoembolization & microwave ablation) of hepatocellular carcinoma
by: Aya Ahmed Elboghdady, et al.
Published: (2023-12-01)

Usefulness of Modified CEUS LI-RADS for the Diagnosis of Hepatocellular Carcinoma Using Sonazoid
by: Katsutoshi Sugimoto, et al.
Published: (2020-10-01)

Ramp Distribution-Based Contrast Enhancement Techniques and Over-Contrast Measure
by: Seungyoun Lee, et al.
Published: (2019-01-01)

Technical note: Radiofrequency ablation of hepatocellular carcinoma with contrast-enhanced ultrasound guidance: First Indian experience
by: Atul Kapoor, et al.
Published: (2011-04-01)

Sonazoid-enhanced ultrasonography for noninvasive imaging diagnosis of hepatocellular carcinoma: special emphasis on the 2022 KLCA-NCC guideline
by: Hyo-Jin Kang, et al.
Published: (2023-10-01)

Complementary Role of CEUS and CT/MR LI-RADS for Diagnosis of Recurrent HCC
by: Mei-Qing Cheng, et al.
Published: (2023-12-01)